Chloroquine drops against SARS-CoV-2 infection
Main Authors: | Jogender Kumar, Jitendra Meena |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Indian Journal of Medical Research |
Online Access: | http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2022;volume=155;issue=1;spage=215;epage=216;aulast=Kumar |
Similar Items
-
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells
by: Carolina Q. Sacramento, et al.
Published: (2022-02-01) -
A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam
by: Kestelyn, E, et al.
Published: (2020) -
Insight into a new discovery of SARS-CoV-2 inhibitor activated through Chloroquine derivatives
by: Mohammed Salah, et al.
Published: (2024-01-01) -
Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
by: Ashutosh Khaswal, et al.
Published: (2022-07-01) -
Acquired immunity against SARS‐CoV‐2 infection and vaccination
by: Laurent Renia, et al.
Published: (2023-12-01)